CBI's Strategies for Comparator Studies: Register Early and Save

Company News Release

Register by  March 13th and SAVE $300*!
 (Mention Promo Code:
JZT974)

RegisterRequest BrochureView Website 
 
   
Conference Chairman: Tony Dutta, Senior Vice President of Operations, IDISElite Speakers Include: Zareen Ahmed, Corporate Regulatory Affairs-Regulatory CMC, sanofi-aventis David Bernstein, Ph.D., Consultant, Bernstein CMC Regulatory Consulting Christina Butta, Senior Principal Scientist, Pfizer Inc Tiffany Cavallaro, Clinical Supply Planning Manager, Merck Scott Eaton, Regulatory CMC, Pfizer Inc Jim Krupa, Associate Director, Planning and Coordination, Cephalon Micheline Marshall, Director, Clinical Pharmacy, Wyeth Gail Owens, Corporate Regulatory Affairs-RCMC, sanofi-aventis Frank Reale, Associate Director, Worldwide Regulatory Coordination and Clinical Supplies, Merck John Simmons, CMC Consultant; Former Director, Office of New Drug Quality Assessment, FDA Mark Ware, Director, Clinical Trial Services, IDIS Jill Wechsler, Washington Editor, Pharmaceutical Executive Yolanda Bell, Global NAMP Business Process  Owner,  Amgen Chris Wilson, Chief Operating Officer, Keats Healthcare Ltd
 
www.cbinet.com/comparator
The First and Only Source for Invaluable Information on:

Market Dynamics Driving an Increase in Comparator Studies and Keys to Success

  • Understand comparative effectiveness and your role in the conduct of superiority studies
  • Organize feasibility groups and implement proven pre-study planning activities
    Best Practices for Internal and External Comparator Sourcing
  • Mitigate the operational, regulatory, commercial and financial risks associated with comparator studies
  • Move from a position of reactive procurement to a proactive and strategic approachCMC Requirements and Regulatory Affairs
  • Establish equivalency of externally sourced and regionally marketed products
  • Use a single comparator in a multi-national study where not every country has approved the comparatorComparator Blinding and Stability Testing
  • Develop methods and specifications for blinded comparators
  • Minimize assays for the analytical testing of blinded comparatorsREGISTER NOW! Registration Fees:  

Selection:Register by 3/13/09  Standard      
 2-Day Conference  $1695$1995           
   

Conference Co-Sponsor:
http://www.idispharma.com/

 
 2009 Sponsors:
http://www.myoderm.com/, http://www.myoderm.com/, http://www.almacgroup.com/pharmaservices/, http://www.adiramedica.com/, http://www.pharmarama.com/about.htm, http://www.bilcare.com/, http://www.keatshealthcare.co.uk/, http://www.multipharma.ch/

  • Organized by The Center for Business Intelligence:
    CBI is a world-class conference company that focuses on producing high-level programs for executive decision-makers who face strategic issues in domestic and international markets. CBI's Pharmaceutical and Biotech Division produces some of the most innovative and “must attend” events for the pharmaceutical and biotech industries.

  • *Discount offer can not be combined with other discounts or applied to a current registration.

Offer not valid on workshop only or academic registrations.